Nephro Care India Limited (NSE:NEPHROCARE)

India flag India · Delayed Price · Currency is INR
86.65
+0.35 (0.41%)
At close: Apr 28, 2026
-39.51%
Market Cap 1.43B
Revenue (ttm) 761.59M
Net Income (ttm) 30.91M
Shares Out 16.49M
EPS (ttm) 1.61
PE Ratio 53.68
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,800
Average Volume 22,860
Open 85.50
Previous Close 86.30
Day's Range 85.00 - 88.05
52-Week Range 50.05 - 183.00
Beta n/a
RSI 64.61
Earnings Date May 26, 2026

About Nephro Care India

Nephro Care India Limited, provides treatment for kidney-related diseases in India. The company offers care for renal failure patients that include consultation, treatment, and yoga; nutritional support, including nutritional support for weight loss/weight gain, body composition analysis, anthropometry, and lifestyle education and support services for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, lupus nephropathy, and ADPKD; and lifestyle and rehabilita... [Read more]

Industry Hospitals
Founded 2014
Employees 334
Stock Exchange National Stock Exchange of India
Ticker Symbol NEPHROCARE
Full Company Profile

Financial Performance

In fiscal year 2025, Nephro Care India's revenue was 460.31 million, an increase of 69.04% compared to the previous year's 272.31 million. Earnings were 36.39 million, a decrease of -17.51%.

Financial Statements

News

There is no news available yet.